Audiometric Test: Clinical Trials

3 trials of Audiometric Test, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 11Recruiting 1
Phase 31Recruiting 1

Follow Audiometric Test: new trials by email Literature Review of Audiometric Test trials Research Report on Audiometric Test

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
Audiometric Test, Cisplatin, Computed Tomography - Hearing Loss, Metastatic Malignant Germ Cell Tumor
Phase 1RecruitingCity of Hope Medical Center442026-02-192026-04-17
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Audiometric Test, Interview - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck
Not applicableRecruitingEmory University1182025-08-252026-07-16
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Audiometric Test, Auditory Brainstem Response, Biospecimen Collection - Childhood Medulloblastoma
Phase 3RecruitingChildren's Oncology Group2252023-02-202026-08-25

Conditions studied

Carcinoma (1)  ·  Hearing Loss (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Medulloblastoma (1)  ·  Mouth Neoplasms (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Oropharyngeal Neoplasms (1)  ·  Seminoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Testicular Neoplasms (1)

Sponsors

Children's Oncology Group (1)  ·  City of Hope Medical Center (1)  ·  Emory University (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Alex Chehrazi-Raffle (1)  ·  Nicole C Schmitt, MD, FACS (1)  ·  Ralph Salloum (1)

NIH funding

K24DC022077 (1), P30CA033572 (1), P30CA138292 (1), U10CA180886 (1)